Gadelha MR - Search Results

1

[Acute test with subcutaneous octreotide as a predictor of the response to treatment with octreotide LAR].

Taboada GF, Donangelo I, Guimarães RF, Silva Mde O, Fontes R, Gadelha MR. Taboada GF, et al. Among authors: gadelha mr. Arq Bras Endocrinol Metabol. 2005 Jun;49(3):390-5. doi: 10.1590/s0004-27302005000300010. Epub 2006 Mar 16. Arq Bras Endocrinol Metabol. 2005. PMID: 16543993 Portuguese.

2

Optic pathways tuberculoma mimicking glioma: case report.

Aversa do Souto A, Fonseca AL, Gadelha M, Donangelo I, Chimelli L, Domingues FS. Aversa do Souto A, et al. Surg Neurol. 2003 Oct;60(4):349-53. doi: 10.1016/s0090-3019(03)00133-2. Surg Neurol. 2003. PMID: 14505863

3

Dependency and analgesia related to treatment with subcutaneous octreotide in patients with growth hormone-secreting tumors.

Donangelo I, Rodacki M, Peixoto MC, Vaisman M, Caldas NR, Gadelha MR. Donangelo I, et al. Among authors: gadelha mr. Endocr Pract. 2004 Mar-Apr;10(2):107-11. doi: 10.4158/EP.10.2.107. Endocr Pract. 2004. PMID: 15256326

4

[Molecular basis of pituitary adenomas with emphasis on somatotropinomas].

Donangelo I, Gadelha M. Donangelo I, et al. Arq Bras Endocrinol Metabol. 2004 Aug;48(4):464-79. doi: 10.1590/s0004-27302004000400006. Epub 2005 Mar 7. Arq Bras Endocrinol Metabol. 2004. PMID: 15761509 Review. Portuguese.

5

Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas.

Donangelo I, Marcos HP, Araújo PB, Marcondes J, Filho PN, Gadelha M, Chimelli L. Donangelo I, et al. Endocr Pathol. 2005 Spring;16(1):53-62. doi: 10.1385/ep:16:1:053. Endocr Pathol. 2005. PMID: 16000847

6

Tumor deletion mapping of chromosomal region 13q14 in 43 growth hormone secreting pituitary adenomas.

Donangelo I, Araújo PB, Antenuzi D, Farage M, Marcondes J, Filho PN, Gadelha MR. Donangelo I, et al. Among authors: gadelha mr. Endocrine. 2005 Nov;28(2):131-6. doi: 10.1385/endo:28:2:131. Endocrine. 2005. PMID: 16388084

7

Etiologic aspects and management of acromegaly.

Taboada GF, van Haute FR, Corrêa LL, Casini AF, Gadelha MR. Taboada GF, et al. Among authors: gadelha mr. Arq Bras Endocrinol Metabol. 2005 Oct;49(5):626-40. doi: 10.1590/s0004-27302005000500004. Epub 2006 Jan 23. Arq Bras Endocrinol Metabol. 2005. PMID: 16444346 Review.

8

[Cardiac morphology and performance alterations and analysis of determinant factors of left ventricular hypertrophy in 40 patients with acromegaly].

Casini AF, Araújo PB, Fontes R, Xavier SS, Gadelha MR. Casini AF, et al. Among authors: gadelha mr. Arq Bras Endocrinol Metabol. 2006 Feb;50(1):82-90. doi: 10.1590/s0004-27302006000100012. Epub 2006 Apr 17. Arq Bras Endocrinol Metabol. 2006. PMID: 16628279 Portuguese.

9

Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas.

Taboada GF, Luque RM, Bastos W, Guimarães RF, Marcondes JB, Chimelli LM, Fontes R, Mata PJ, Filho PN, Carvalho DP, Kineman RD, Gadelha MR. Taboada GF, et al. Among authors: gadelha mr. Eur J Endocrinol. 2007 Jan;156(1):65-74. doi: 10.1530/eje.1.02313. Eur J Endocrinol. 2007. PMID: 17218727

10

Two hour mean GH is not superior to basal GH for the follow-up of acromegalic patients treated with Octreotide LAR.

Taboada GF, Correa LL, de Oliveira Machado E, van Haute FR, Casini AF, Balarini GA, Neto LV, Calixto L, Calixto C, Gadelha MR. Taboada GF, et al. Among authors: gadelha mr. Growth Horm IGF Res. 2007 Feb;17(1):77-81. doi: 10.1016/j.ghir.2006.12.003. Epub 2007 Feb 20. Growth Horm IGF Res. 2007. PMID: 17314058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters